These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18574015)

  • 1. Once-weekly vancomycin for patients receiving high-flux hemodialysis.
    Crawford BS; Largen RF; Walton T; Doran JJ
    Am J Health Syst Pharm; 2008 Jul; 65(13):1248-53. PubMed ID: 18574015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y; Hernández Castillo R; Santiago E; Ramírez Yuch N; Jaume Anselmi F; Jové R; Flores R; Lebrón R; Ramírez Rivera J
    Bol Asoc Med P R; 2012; 104(3):10-4. PubMed ID: 23156886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH; DeVincenzo N
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis.
    Pollard TA; Lampasona V; Akkerman S; Tom K; Hooks MA; Mullins RE; Maroni BJ
    Kidney Int; 1994 Jan; 45(1):232-7. PubMed ID: 8127014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin hemodialysis: Clearance differences between high-flux hemodialysis and on-line hemodiafiltration.
    Rodríguez N; Gómez M; Rico N; María Campistol J; Maduell F
    Artif Organs; 2019 Mar; 43(3):261-269. PubMed ID: 30302764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.
    Crew P; Heintz SJ; Heintz BH
    Am J Health Syst Pharm; 2015 Nov; 72(21):1856-64. PubMed ID: 26490819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
    Hui K; Patel K; Nalder M; Nelson C; Buising K; Pedagogos E; Kong DCM; Kirkpatrick CMJ
    J Antimicrob Chemother; 2019 Jan; 74(1):130-134. PubMed ID: 30215721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
    Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL; Mueller BA; Scott MK; Carfagna MA; Kraus MA
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of vancomycin administered during dialysis by a high-flux dialyzer.
    Nyman HA; Agarwal A; Senekjian HO; Leypoldt JK; Cheung AK
    Hemodial Int; 2018 Jul; 22(3):383-387. PubMed ID: 29380499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
    Glover ML; Cole E; Wolfsdorf J
    J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin Dosing Regimen by Monte Carlo Simulation in Patients on Intermittent High-Efficiency Hemodialysis (HEHD).
    Rungprai D; Jaruratanasirikul S; Wongpoowarak W; Pattharachayakul S; Wanakamanee U; Dandecha P; Jitsurong A
    J Med Assoc Thai; 2015 Jun; 98(6):606-15. PubMed ID: 26219166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of vancomycin in sustained low-efficiency dialysis (SLED): a need for better surveillance and dosing.
    Golestaneh L; Gofran A; Mokrzycki MH; Chen JL
    Clin Nephrol; 2009 Oct; 72(4):286-91. PubMed ID: 19825334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.